Literature DB >> 21828057

Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.

Takeshi Motohara1, Sachiko Masuko, Takatsugu Ishimoto, Toshifumi Yae, Nobuyuki Onishi, Teruyuki Muraguchi, Atsushi Hirao, Yumi Matsuzaki, Hironori Tashiro, Hidetaka Katabuchi, Hideyuki Saya, Osamu Nagano.   

Abstract

Although the existence of tumor-initiating cells (T-ICs) in several types of human cancer has been documented, the contribution of somatic stem cells to the development of T-ICs has remained unclear. Here, we show that normal mouse ovary contains epithelial cell adhesion molecule (EpCAM)-expressing stem-like cells that possess the ability to differentiate into cytokeratin 8 (CK8)-expressing epithelial progeny cells. Furthermore, RNA interference-mediated transient depletion of the tumor suppressor p53 followed by retrovirus-mediated transfer of c-Myc and K-Ras oncogenes in EpCAM-expressing ovarian stem-like cells resulted in the generation of ovarian T-ICs. The established ovarian T-ICs gave rise to hierarchically organized lethal tumors in vivo and were able to undergo peritoneal metastasis. Finally, subsequent RNA interference-mediated knockdown of p53 in tumor cells triggered the expansion of EpCAM-expressing stem-like tumor cells and induced further tumor growth. These data reveal a role for p53 in the development and expansion of ovarian stem-like tumor cells and subsequent malignant progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828057     DOI: 10.1093/carcin/bgr183

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  26 in total

1.  Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.

Authors:  Toshifumi Yae; Kenji Tsuchihashi; Takatsugu Ishimoto; Takeshi Motohara; Momoko Yoshikawa; Go J Yoshida; Takeyuki Wada; Takashi Masuko; Kaoru Mogushi; Hiroshi Tanaka; Tsuyoshi Osawa; Yasuharu Kanki; Takashi Minami; Hiroyuki Aburatani; Mitsuyo Ohmura; Akiko Kubo; Makoto Suematsu; Kazuhisa Takahashi; Hideyuki Saya; Osamu Nagano
Journal:  Nat Commun       Date:  2012-06-06       Impact factor: 14.919

Review 2.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

3.  MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

Authors:  Hirofumi Akita; Jens U Marquardt; Marian E Durkin; Mitsuteru Kitade; Daekwan Seo; Elizabeth A Conner; Jesper B Andersen; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Cancer Res       Date:  2014-09-04       Impact factor: 12.701

Review 4.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Isolation of side population cells from endometrial cancer cells using a violet laser diode.

Authors:  Satoshi Tomiyasu; Tomoyuki Miyamoto; Michihiro Mori; Takahiro Yaguchi; Hiromasa Yakushiji; Setsuyo Ohno; Yasuyuki Miyake; Takuya Sakaguchi; Masatsugu Ueda; Eiji Ohno
Journal:  Hum Cell       Date:  2013-10-04       Impact factor: 4.174

6.  Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.

Authors:  Sichuan Xi; Hong Xu; Jigui Shan; Yongguang Tao; Julie A Hong; Suzanne Inchauste; Mary Zhang; Tricia F Kunst; Leandro Mercedes; David S Schrump
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

Review 7.  Dynamic regulation of cancer stem cells and clinical challenges.

Authors:  Chao Ni; Jian Huang
Journal:  Clin Transl Oncol       Date:  2012-08-28       Impact factor: 3.405

Review 8.  Regulation of ovarian cancer stem cells or tumor-initiating cells.

Authors:  Mi Jeong Kwon; Young Kee Shin
Journal:  Int J Mol Sci       Date:  2013-03-25       Impact factor: 5.923

9.  Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer.

Authors:  B T F van der Gun; C Huisman; S Stolzenburg; H G Kazemier; M H J Ruiters; P Blancafort; M G Rots
Journal:  Br J Cancer       Date:  2013-02-12       Impact factor: 7.640

10.  Technical challenges and limitations of current mouse models of ovarian cancer.

Authors:  Kenneth Garson; Lisa F Gamwell; Elizabeth Mg Pitre; Barbara C Vanderhyden
Journal:  J Ovarian Res       Date:  2012-11-29       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.